Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Kymera Therapeutics (KYMR): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
34 analysts
Options Flow (P/C)
—
Avg Consensus PT
$119
-1.8%
Highest Price Target
$170
+40.4%
Lowest Price Target
$44
-63.7%
Short Interest
12.6%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Barclays | Eliana Merle— | +40.4% | $139 → $170 | Maintained | Overweight |
| Oct 30, 2026 | Truist Securities | Srikripa Devarakonda— | +23.9% | $136 → $150 | Maintained | Buy |